11/07/2024
5:08 AM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/05/2024
3:13 PM | Magrath George (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
4:07 PM | Opus Genetics, Inc. (Filer)
Opus Genetics, Inc. (Filer)
Opus Genetics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/29/2024
4:26 PM | Foundation Fighting Blindness Retinal Degeneration Fund (Filed by)
Opus Genetics, Inc. (Subject)
Opus Genetics, Inc. (Subject)
Opus Genetics (Subject)
| Form SC 13D | |
10/29/2024
4:10 PM | Foundation Fighting Blindness Retinal Degeneration Fund (Reporting)
Foundation Fighting Blindness, Inc. (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2024
4:54 PM | Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
YERXA BENJAMIN R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2024
4:56 PM | Bennett Jean (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/24/2024
4:59 PM | Graves Adrienne L (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
4:49 PM | Bennett Jean (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/24/2024
4:52 PM | Graves Adrienne L (Reporting)
Opus Genetics, Inc. (Issuer)
Opus Genetics, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
4:09 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:14 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
4:30 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
Pepose Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:31 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:23 PM | Ainsworth Sean (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:25 PM | Benton Susan (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:27 PM | Gallagher Cam (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:28 PM | MANUSO JAMES S J (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:06 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:07 PM | Jayagopal Ashwath (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:18 PM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:35 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
7:12 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:43 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form DEFA14A | |
04/29/2024
3:45 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form ARS | |
04/19/2024
4:28 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form PRE 14A | |
04/17/2024
3:23 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:18 PM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:20 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2024
7:21 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:31 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 424B3 | |
02/14/2024
5:32 PM | Jhaveri Nirav S. (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2024
5:35 PM | Jayagopal Ashwath (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:37 PM | Jhaveri Nirav S. (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:29 PM | Jayagopal Ashwath (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/23/2024
11:15 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form EFFECT | |
01/22/2024
5:01 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
Zaremba Rabourn Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:01 PM | Hoffmann Bernhard (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:16 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/10/2024
4:00 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/03/2024
4:57 PM | Benton Susan (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Download Our Tesla Ebook For Free (Ad) Like many of you, we here at the TradingPub are bullish on Tesla long term.
We believe the company will continue to be a leader in technology, EVs and A.I.
We also believe it’s share price will be rewarded in a big way…
In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. |
12/05/2023
3:30 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
Patel Ronil A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:19 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
SCHACHLE JOSEPH K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/27/2023
5:24 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma, Inc. (Issuer)
Opus Genetics (Issuer)
SCHACHLE JOSEPH K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
7:45 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma, Inc. (Filer)
Opus Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
